Back to Journals » Journal of Asthma and Allergy » Volume 14

Corrigendum

Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]

       
Total article views   HTML views PDF downloads Totals
2,571 Dovepress* 2,481+ 324 2,805
PubMed Central* 90 42 132
Totals 2,571 366 2,937
*Since 29 June 2021

View citations on PubMed Central and Google Scholar